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Commentary

Controversy on Prophylactic Oophorectomy

Abstract: The merits of prophylactic
oophorectomy at the time of hysterectomy
have been debated for many years. The most
compelling argument for prophylactic
removal of the ovaries has always been the
prevention of ovarian cancer (2).
Prophylactic oophorectomy has advantages
and disadvantages. The actual incidence of
cancer in retained ovaries is difficult to
estimate. The advantages of prophylactic
oophorectomy include the prevention of
ovarian cancer, the alleviation of symptoms
from residual ovary syndrome and the
elimination of the need for reoperation for
adnexal disease (2). Disadvantages include
surgical castration, which results in the need
for hormone replacement, and changes in
self-image (2). In addition, when
oophorectomy is performed, the germinal,
steroidal and hormonal functions of the ovary
are lost, but the nonsteroidal functions
continue during natural menopause.
Prophylactic oophorectomy in premenopausal

Introduction
Ovarian cancer is the fifth leading cause of cancer
death in women and the leading form of fatal gynecologic
cancer (1). One simple and effective method of
prevention is prophylactic oophorectomy in women
undergoing hysterectomy for gynecologic indications (2).
However, prophylactic oophorectomy has disadvantages
as well.
Menopause is that point in time when permenant
cessation of menstruation occurs following the loss of
ovarian activity. The median age for the onset of
perimenopause is 47.5 years.
Only 0.88 percent of women reach menopause at 4044 years of age. According to Novak, after 50 years of
age, only 23% of women show ovulation histologically.
Consequently, patients who undergo bilateral
oophorectomy at 40-45 years age lose 10 years of their

women induces surgical menopause,
requiring estrogen replacement to prevent
symptoms and diseases associated with
menopause (2). Consideration should be
given to prophylactic oophorectomy in
younger women undergoing pelvic surgery if
they have high risk factors (3). Although
prophylactic oophorectomy may not
completely eliminate the potential for intraabdominal carcinomatosis (4), it remains an
effective strategy for the prevention of
ovarian cancer. The use of this approach is
not limited by age. Advances in medical
technology, especially in medical genetics,
have led to potentially useful techniques for
the early detection of epithelial ovarian
cancer and high risk women.
Key Words: Ovarian remnant syndrome,
hysterectomy, ovarian cancer, prophylactic
oophorectomy, ovarian residual syndrome.

ovarian function. The proper decision as to whether to
retain or remove normal appearing ovaries during
hysterectomy has plagued physicians for many years. The
following questions need to be addressed:
• After menopause, do the ovaries continue their
functions?
• After menopause, should the ovaries remain?
• After 50 years of age is it necessary to perform
prophylactic oophorectomy because of the increased rate
of ovarian cancer.
To answer some of the questions, we must also take
into consideration nonsteroidal ovarian secretions,
including the following:
Growth factors
• Epidermal growth factor
• Transforming growth factors a and b
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The number of patients

Ages (median)

Standard deviation

Surgical menopause

218

47.2

3.6

Natural Menopause

269

49.2

3.9

Total

468
Cholesterol

Triglyceride

HDL-c

LDL-c

VLDL-c

Surgical M.

249.6

185.8

45.4

163.3

40.8

Natural M.

228.4*

142.6*

59.1*

141.4*

27.9*

Table 1.

The distribution of patients.

Table 2.

Comparison of serum lipid
profiles in surgical and natural
menopause

Table 2.

Comparison of serum lipid
profiles in surgical and natural
menopause

*P<0.05
40-45 years of age

46-50 years f age

>50 years of age

Spinal BMD
Surgical M

0.8504

0.8860

0.8561

Natural M.

0.8545

0.8589*

0.8927

Surgical M.

0.8140

0.8638

0.8941

Natural M.

0.8853

0.8673

0.8862

Femoral BMD

*P<0.05

• Fibroblast growth factor
• Insulin-like growth factors I and II

5. Increased risk of cardiovascular disease due to the
negative effect of oophorectomy on serum lipids (2).

Study Reports

Glycoprotein/peptide regulator substances
• Inhibin
• GnRH-like substances
• Follistatin
• Relaxin
• Activin
• Renin and angiotensin
Glycoamynoglycans
• Condroitan sulphate
• Heparan sulphate
• Dermatan sulphate
The disadvantages of performing hysterectomy plus
bilateral salpingo-oophorectomy include the following:
1. Psycosomatic disorders
2. Genitourinary disorders
3. Ovarian remnant syndrome
4. Premature serious osteoporosis
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Study 1
At the gynecology clinic at Dr. Zekai Tahir Burak
Women’s Hospital, Basaran et al. conducted a study on
ovarian blood-flow doppler and ovarian hormones in
women who had undergone hysterectomies without
removal of the ovaries. They performed their study on
seventy-three patients, forty-three of whom comprised
the study group and thirty the control group.
Ovarian artery blood-flow doppler was evaluated
preoperatively, and postoperatively at the third month.
Ovarian hormone values were evaluated preoperatively,
and postoperatively on the fifth day and at the third
month.
Preoperative and the postoperative third-month
ovarian artery blood flow measurements in the right and
left ovaries were not significantly different.
In forty-three patients, estradiol levels were
statistically low for the postoperative fifth day. At the
postoperative third month we found no difference
between the two groups.
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In the hysterectomies where the ovaries were
preserved, we saw temporary calmness but at the
postoperative third month ovarian blood supply was
sometimes seen to return to its normal levels. Naturally in
the beginning, the blood supply that comes from
ligamentum ovarii proprium is lost, and therefore the
functional effect is decreased.

Study 2
Oransay et al. performed a study at the menopause
clinic at Dr. Zekai Tahir Burak Women’s Hospital. They
encountered postmenopausal lipid profiles in patients
with surgical menopause and natural menopause. Of the
four hundred sixty-eight patients included in the study,
two hundred eighteen (aged 47.2±3.6 SD) had cesed
menstruating because of hysterectomy and bilateral
salphingooophorectomy. Two hundred sixty-nine (aged
49.2±3.9SD) had undergone natural menopause. SD. The
distribution of patients is shown in Table 1.
In the group whose ovaries were removed, the serum
lipids LDL-c, VLDL-c increased rapidly, and there was
increased incidence of cardiovascular disease. Estrogen
replacement therapy is an effective treatment for these
problems in the majority of women. When estrogen
therapy is contraindicated, the decision whether or not to
remove the ovaries must be made with great care.

Study 3
Oransay et al. performed another study at the
menopause clinic at Dr. Zekai Tahir Burak Women’s
Hospital on the effect of surgical and natural menopause
on spinal and femoral bone mineral density.
In Table 3, spinal and femoral bone mineral density
over five years are compared.
In patients aged 46 to 50 who had undergone
oophorectomy, spinal bone mineral density was found to
have decreased significantly.

Study 4
The menopause clinic at Dr. Zekai Tahir Burak
Women’s Hospital, a study was conducted on eight
hundred seventy-seven premenopausal and four thousand
twenty postmenopausal patients.
Loss of libido was found in 56.21% of premenopausal
and 6.46% of postmenopausal patients.
A 40-year-old patient who has undergone total
abdominal hysterectomy plus bilateral salpingooophorectomy has the same vaginal dryness as a 60-yearold. Hysterectomy plus oophorectomy at such an age has
a negative effect on a patient’s psycological and
physiological life.

What are the long-term effects of hysterectomy on
the ovaries of normal women?
Much is known about menstrual cyclicity (5, 6) and
luteal function. (6, 7, 8, 9) in normal women, but little
about the ovarian cycles of women who have no uterus.
In normal women, a sudden break in a regular pattern of
ovulatory menstrual cycles is often the first sign of the
ovarian dysfunction which will eventually lead to
menopause (10).
Seidenschnur et al. performed a study on four
hundred eighty-eight vaginally or abdominally
hysterectomized women involving retrospective
questionnaires
about
preoperative
anxieties,
postoperative psyhcosomatic complaints and disturbances
of their vita sexualis (11). Prior to operation and
anesthesia, 48.6% of the patients experienced anxiety.
Following hysterectomy, 71.9% of the women reported
hot flushes and other psychovegetative complaints.
Although hot flushes occurred significantly more
frequently in patients with salphingo-oophorectomy,
these complaints were also reported in one third of the
women whose ovaries had not been removed. Libido,
cohabitation, frequency and orgasm ability were
significantly lower in the group of women who had
undergone salpingo-oophorectomy. This is caused by the
reduced blood supply to the ovary via branches of the
uterine artery. On no account should a prophylactic
extirpation of the adnexa be carried out before the age of
50. Hormonal substituion should be done promptly even
with patients whose ovaries have not been removed but
who suffer from psychosomatic discomforts (11).
At the University of Kiel Obstetrics and Gynecology
clinic, Riedel et al. performed a study on patients between
27 and 42 years of age who had been hysterectomized
(12). Of one hundred sixty-four answered questionnaires,
39% typical signs of ovarian failure. The average
progesterone and estrogen concentrations in the
suspected luteal phases were lower than in healthy
women in the same age group.
After hysterectomy, ovarian failure phenomena can be
excepted to develop to a considerable degree in 30-50%
of patients (12). The primary and secondary
complications of hysterectomy, whether abdominal or
vaginal, are much more pronounced than after
laparoscopic tubal sterilization. Even after hysterectomy
with both ovaries left intact, ovarian failure phenomena
may follow, and these patients should not undergo
psychotherapy but rather hormone therapy (12).
The effects of premenopausal hysterectomy on
ovarian endocrine function have so far been insufficently
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studied, although menopause is not believed to begin
earlier in hysterectomized patients than in healthy women
(13). Many hysterectomized patients have climacteric
symptoms (hot flushes, vertigo) at a younger age than
women with a uterus (12, 14). This suggests that ovarian
function may cease earlier after hysterectomy, and
hormonal replacement therapy might be indicated for
such patients (12). Acute luteal progesterone deficiency
after hysterectomy in premenopausal women is common
but in most cases reversible (12). The reason for the
changes in ovarian function may be surgical stress and
perhaps the acute changes in ovarian blood supply
compensated for later (15). Anaesthetics may have
transient effects on gonadotrophin secretion and on the
luteal phase (16).
What is the role of the uterus in the associated
etiology of premenstrual syndrome (PSM)?
Hysterectomy has been associated with a 66%
reduction in mean premenstrual tension (PMT) severity
for both psychological and physical symptoms (17).
There is also evidence that in some women PMT is
strongly influenced by factors associated with the ovarian
hormone cycle (17). According to present knowledge,
hysterectomy is not an appropriate treatment for PMT
(17). The only clear indication for hysterectomy would be
the demonstration that PMT was strongly influenced by
factors associated with the uterus (17).
Hysterectomy is the most common major operative
procedure (18). Ovarian cancer continues to be one of the
most lethal forms of cancer in women, with a five-year
survival rate in no more than 40% of patients in the past
50 years (19).
The aging normal ovary presents a dilemma at the
time of hysterectomy. Removal of both ovaries prevents
ovarian cancer, but castration without estrogen
replacement therapy has adverse effects, particularly in
younger women (20, 21).
The proper decision as to whether to retain or remove
normal appearing ovaries at hysterectomy has plagued
physicians for many years. Past practice was routine
removal of normal appearing ovaries in women over 4044 years of age during hysterectomy (21, 22).
Physicians facing this decision should consider
epidemiologic risk factors to determine the likehood of
the patient’s developing ovarian cancer or osteoporosis
(19). Both patient and physician must be aware,
particularly if the patient is from a family prone to
ovarian cancer, of the possibility of the future
development of an intra-abdominal malignancy, usually
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multifocal peritoneal carcinoma, which is almost
indistinguishable histopathologically from ovarian cancer
(4).
The recognition of risk factors associated with ovarian
cancer of the epithelial cell type of osteoporosis should be
balanced against the fact that there is a 21% survival rate
for a woman undergoing hysterectomy with retention of
one or both ovaries who later develops invasive ovarian
cancer (18).
Over 50 years of age the risk of ovarian cancer is
0.15%. Randall et al. performed a study on 1000
patients who had undergone hysterectomy plus
oophorectomy. Only three were found to have had
previous cancers, two of endometrial origin and one
adenocarcinoma of the cervix. A dictum as to age for the
removal or retension of normal-appearing ovaries during
hysterectomy is not always possible, and it may be better
to individualize each woman’s risk factors (23).
The reported reoperation rate on unremoved ovaries
ranges from 0.9 to 5.2% (24).
The second operation is usually indicated for cysts,
hydrosalpnx or adhesions. 5.1% of the patients suffered
from residual ovarian syndrome. Ten years after
hysterectomies in which the ovaries are preserved, the
risk of developing a benign ovarian tumor is 1%, while
the risk of ovarian cancer is 0.1-0.2%. In a study by from
Larry Mc Gowans, 80% of the subjects had had
abdominal hysterectomies at an average age of 41, and
20% had had vaginal hysterectomies at an average age of
46. The average interval between hysterectomy and
discovery of ovarian cancer was 18 years in the
abdominal group and 10 years in the vaginal group (18).
Review of the literature reveals a 4.5-14.1%
incidence of prior hysterectomy in women developing
ovarian cancer (2). Between 1977-1990, seven hundred
fifty-five women were evaluated and treated for ovarian
cancer at the University of Miami Jackson Memorial
Medical Center (2). One simple and effective method of
prevention is prophylactic oophorectomy in women
undergoing hysterectomy for gynecologic indications. If
all the women treated for ovarian cancer at the University
of Miami Jackson Memorial Medical Center (2). One
simple and effective method of prevention is prophylactic
oophorectomy in women undergoing hysterectomy for
gynecologic indications. If all the women treated for
ovarian cancer at the University of Miami Medical Center
during a 14-year period who underwent hysterectomy
after age 40 had had their ovaries removed, 60 cases
(7.9%) of ovarian cancer would have been prevented (2).

Controversy on Prophylactic Oophorectomy

The value of prophylactic oophorectomy at the time of
hysterectomy has been debated for many years (2). The
most compelling argument for prophylactic removal of
the ovaries has always been the prevention of ovarian
cancer (2).
Other advantages include alleviation of symptoms of
residual ovary syndrome and elimination of the need for
reoperation for adnexal disease (2). The risk of a woman
developing ovarian cancer is 1.4% (24), and previous
studies have reported an incidence of up to 1.2% in
retained ovaries (3).
Conversely, 4.5-14.1% of women with ovarian cancer
have undergone a previous hysterectomy with
preservation of one or both ovaries (2). Unilateral
oopherectomy at the time of hysterectomy does not
eliminate the risk of ovarian cancer (23). Disadvantages
of routine prophylactic oophorectomy include surgical
castration, resulting in the need for hormone
replacement, and changes in self-image (2).
Prophylactic oophorectomy in premenopausal women
induces surgical menopause, requiring estrogen
replacement to prevent symptoms, and diseases
associated with menopause (vasomotor instability,
atrophic changes of the genital tract, osteoporosis and
increased incidence of cardiovascular disease) (2). Sterling
et al. recommend routine bilateral prophylactic
oophorectomy for all women undergoing hysterectomy
after the age of 40 (2). Prophylactic oophorectomy
would also prevent the need for reoperation for benign
adnexal disease in up to 5% of women (3).
Although prophylactic oophorectomy may not
completely eliminate the potential for intra-abdominal
carcinomatosis, it remains an effective strategy for the
prevention of ovarian caancer (4).
Between 1989-1995, one hundred eighty-six patients
were evaluated and treated for ovarian pathology at the
oncology at Dr. Zekai Tahir Burak Women’s Hospital. Five
had
had
previous
hysterectomy
or
hysterectomy+unilateral oophorectomy. Of these five,
two had benign and three had malignant pathology.
During the same years at this hospital, 1,020 patients
who had previously undergone hysterectomy with
preservation of one or both ovaries were evaluated and
treated at the gynecology department. The incidence of
ovarian tumours among these patients was 0.3%, more
than half of which (0.19%) had malignant pathology.
Between 42 and 45 years of age, the indications for
removal of functioning ovaries during hysterectomy are
as follows (18):
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1. Peutz-Jeghers syndrome
2. Never having conceived despite the absence of
contraception
3. Inital primary malignancy of the breast
endometrium or colon which has a high association with
subsequent ovarian cancer.
4. Cervical adenocarcinoma
5. Family history of ovarian cancer (the incidence is
12% (5-19))
6. Ovarian abscess, cyst, endometriozis, tumour,
infection
Although the majority of ovarian neoplasms occur in
the absence of familial or heritable components, many
key observations have been made during the past eight
years concerning the genetic alterations associated with
this disease (25). Both epidemiology and molecular
biology may be used to identify a subset of women who
are likely to be at increased risk of developing ovarian
cancer (25). A number of genes are known to be involved
in inherited susceptibility to breast and/or ovarian cancer.
In the context of high-risk families, the most important
genes are BRCA1 on chromosome 17q, which is
associated with a high penetrance of both breast and
ovarian cancer and BRCA2 on chromosome 13q, which is
associated with a high risk of breast cancer but a lower
risk of ovarian cancer (26).

Ovarian Remnant Syndrome
Ovarian remnant syndrome results from residual
ovarian tissue after bilateral oophorectomy (27). The
syndrome is associated with chronic pelvic pain and is
suspected when premenopausal levels of FSH and LH are
present in a patient with documented bilateral
oopherectomy (27). Pelvic pain with or without a pelvic
mass after hysterectomy plus bilateral salpingooophorectomy constitutes a diagnostic dilemma (28).
Ovarian remnant syndrome results from the incomplete
excision of ovarian cortical tissue and can cause a range of
symptoms from constant or cyclic pelvic pain to bowel
and ureteral obstruction (28). The preoperative diagnosis
of ovarian remnant syndrome is made by history and
physical examination, with findings confirmed by
ultrasound studies and steroid and gonadotropin
hormone assays (28). The syndrome is probably more
prevalent than is generally recognized, and it may be
misdiagnosed by even experienced clinicians (28).
Symptoms may occur 1-5 years after the operation. The
most effective treatment for ovarian remnant sydrome is
surgical excision of the residuum with adequate margins
to insure that all active tissue is removed (28, 29).
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Medical therapy is empiric, and hormonal manipulation
with newer gonadotropin suppressors and analogs may
prove effective in this syndrome (30). Laparoscopy is of
little value in the diagnosis or treatment of patients who
have already undergone multiple operations for pelvic
adhesive disease (28). The best way to prevent this
complication is to remove the ovaries entirely during the
initial operation as well as the pelvic parietal peritoneum,
which may harbor ovarian cortical tissue (28).
Brühwiler and Lüscher presented the second published
case of ovarian cancer in ovarian remnant syndrome. Only
explorative laparotomy confirms the diagnosis (31).

were performed. One or both ovaries were left intact in
three hundred twenty-nine of the patients who
underwent hysterectomies (abdominal+vaginal). On
clinical follow-up examination, six patients (1.8%)
complained of lower abdominal and back pain and deep
dyspareunia (residual ovarian syndrome) (32). When
hysterectomy is performed without removal of both
ovaries, there may be disadvantages:
1. Benign ovarian cysts
2. Ovarian residual syndrome
3. Ovarian malignancies
4. Premature menopause (18)

Ovarian Residual Syndrome
Ovarian residual syndrome appears in some women
after hysterectomy in which one or both ovaries remain
and is characterized by symptoms of lower abdominal and
back pain, deep dyspareunia and disturbance of the
urinary tract (32). In most instances, gynecologic
examination reveals a fixed tender mass near the vaginal
cuff. The frequency of this syndrome is 1-3 percent of all
total abdominal hysterectomies in which one or both
ovaries remain (32). The syndrome is caused by low
grade perioophoritis after surgical treatment prior to
hysterectomy (32). In a study by Bukowsky et al.,
symptoms were found to cease in all patients after
oophorectomy or ovariopexy (32). This suggests a role
for fixating the adnexa in a high position in younger
patients who undergo hysterectomy or fixating the ovary
in a high position and performing salpingectomy because
of tubal involvement in periadnexal adhesions (32).
During the years 1979 to 1983 at the gynecology
department at Assaf Harofe Medical Center, T el-Aviv
University, Zerifin, six hundred and one hysterectomies

Conclusions
Ovarian cancer is the fifth leading cause of cancer
death in women and the leading cause of death from
gynecologic cancer (1). One simple and effective method
of prevention is prophylactic oophorectomy in women
undergoing hysterectomy for gynecologic indications (2).
Prophylactic oophorectomy has advantages and
disadvantages.
The actual incidence of cancer in retained ovaries is
difficult to estimate. The risk of woman developing
ovarian cancer is 1.4% and previous studies have
reported an incidence (24) of up to 1.2% in retained
ovaries (3). Consideration should be given to prophylactic
oophorectomy in younger women undergoing pelvic
surgery if they have high-risk factors (3). Although
prophylactic oopherectomy may not completely eliminate
the potential for intra-abdominal carcinomatosis (4), it
remains an effective strategy for the prevention of
ovarian cancer. This approach is not limited by age.
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